Intragraft angiotropic large-cell lymphoma of T cell-type in a long-term renal allograft recipient.

Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review. J Clin Pathol (2002) 0.85

Intravascular large T-cell lymphoma: a case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression. Virchows Arch (2005) 0.80

Correspondence Re: Ghorbani RP, Shokouh-Amiri H, Gaber L: Intragraft angiotropic large-cell lymphoma of T cell-type in a long-term renal allograft recipient. Mod Pathol 9:671, 1996. Mod Pathol (1996) 0.75

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Comparison of health status and quality of life of related versus paid unrelated living kidney donors. Am J Transplant (2013) 3.04

A review of the evidence for use of thymoglobulin induction in renal transplantation. Transplant Proc (2010) 1.47

Recovery from ischemic acute renal failure is improved with enteral compared with parenteral nutrition. Crit Care Med (1997) 1.44

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation (1998) 1.36

Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg (1996) 1.33

Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg (1996) 1.06

Calcium channel blockade inhibits release of TNF alpha and improves survival in a rat model of acute pancreatitis. Pancreas (1996) 1.05

A technique for portal pancreatic transplantation with enteric drainage. Surg Gynecol Obstet (1993) 1.04

Widespread cytomegalovirus gastroenterocolitis in a patient with acquired immunodeficiency syndrome. Gastroenterology (1983) 1.02

Induction of acute pancreatitis in germ-free rats: evidence of a primary role for tumor necrosis factor-alpha. Surgery (1995) 1.01

Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg (1995) 0.98

Temporal correlation of tumor necrosis factor-alpha release, upregulation of pulmonary ICAM-1 and VCAM-1, neutrophil sequestration, and lung injury in diet-induced pancreatitis. J Gastrointest Surg (2000) 0.96

Percutaneous biopsy of pancreas transplants. Transplantation (1992) 0.92

Congenital nephrosis and neonatal cytomegalovirus infection: a clinical association. Pediatr Nephrol (1993) 0.89

A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage. Ann Surg (2001) 0.86

Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. Surgery (2001) 0.84

Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction. Ann Surg (1999) 0.84

Patterns of acute rejection in portal-enteric versus systemic-bladder pancreas-kidney transplantation. Clin Transplant (1998) 0.84

Pancreas transplantation with portal venous drainage and enteric exocrine diversion: a new technique. Transplant Proc (1992) 0.83

Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis (2003) 0.83

Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis (2001) 0.83

The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients. Clin Transplant (1999) 0.82

Increased recognition of IgA nephropathy in African-American children. Pediatr Nephrol (1997) 0.82

An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation. Transplantation (1995) 0.81

Acute pancreatitis induces cytokine production in endotoxin-resistant mice. Ann Surg (1998) 0.81

The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design. Transplant Proc (1999) 0.81

Pancreas transplantation with portal venous and enteric drainage eliminates hyperinsulinemia and reduces postoperative complications. Transplant Proc (1993) 0.81

Observations on the use of cidofovir for BK virus infection in renal transplantation. Transpl Infect Dis (2014) 0.80

De novo donor specific antibodies and patient outcomes in renal transplantation. Clin Transpl (2011) 0.80

Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection. Transplant Proc (1993) 0.80

Renal pathology in pre-eclampsia. Baillieres Clin Obstet Gynaecol (1987) 0.78

Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation. Transpl Int (2001) 0.78

Incidence of kidney and pancreas rejection following portal-enteric versus systemic-bladder pancreas-kidney transplantation. Transplant Proc (1997) 0.78

Use of glucose disappearance rates (kG) to monitor endocrine function of pancreas allografts. Clin Transplant (1998) 0.78

Terminal complement complexes in acute poststreptococcal glomerulonephritis. Pediatr Nephrol (1994) 0.78

Successful reuse of portal-enteric technique in pancreas retransplantation. Transplantation (2000) 0.77

Simultaneous kidney-pancreas transplantation without antilymphocyte induction. Transplantation (2000) 0.77

The relationship of glucose disappearance rate (kG) to acute pancreas allograft rejection. Transplantation (1994) 0.77

Serial peripheral blood cytotoxic lymphocyte gene expression measurements for prediction of pancreas transplant rejection. Transplant Proc (2006) 0.77

Pregnancy-induced nephropathy: the significance of focal segmental glomerulosclerosis. Am J Kidney Dis (1987) 0.77

Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc (1996) 0.77

A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation. Surgery (2000) 0.77

Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study. Clin Transplant (2000) 0.76

Pediatric IgA nephropathy: clinical features at presentation and outcome for African-Americans and Caucasians. Clin Nephrol (2004) 0.76

Cytokine stimulation of prostaglandin production inhibits the proliferation of serum-stimulated mesangial cells. Kidney Int (1994) 0.76

Nine-year experience with 126 pancreas transplants with portal-enteric drainage. Transplant Proc (2001) 0.76

Interleukin 1 and interleukin 6 inhibition of mesangial cell proliferation: role of PGE2. J Lipid Mediat (1993) 0.75

Patterns of expression of endothelial leukocyte adhesion molecules upon revascularization of transplanted kidneys in correlation with allograft pathology. Transplant Proc (1995) 0.75

Use of glucose disappearance rates to monitor beta-cell function of pancreas allografts. Transplant Proc (1995) 0.75

Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts. Transplant Proc (1998) 0.75

Extragenital metastases to uterine leiomyomata. A case report. J Reprod Med (1992) 0.75

Posttransplant lymphoproliferative disorders: single center experience. Transplant Proc (2001) 0.75

Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis. Clin Transpl (1998) 0.75

Analgesic nephropathy selectively affecting a unilateral non-functioning hypoplastic kidney. Clin Nephrol (2007) 0.75

Improving results in solitary pancreas transplantation with portal-enteric drainage and thymoglobulin induction. Transplant Proc (2002) 0.75

Simultaneous kidney-pancreas transplant with systemic-enteric versus portal-enteric drainage. Transplant Proc (2001) 0.75

The current status of the University of Tennessee, Memphis, experience in pancreas transplantation. Clin Transpl (1992) 0.75

Anti-neutrophil cytoplasmic autoantibodies in a child with pauci-immune necrotizing and crescentic glomerulonephritis. Pediatr Nephrol (1991) 0.75

Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Transplant Proc (1996) 0.75

Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients. Transplant Proc (2003) 0.75

Randomized double-blind study of standard versus low-dose OKT3 induction therapy in renal allograft recipients. Am J Kidney Dis (1993) 0.75

A 9-year experience with 126 pancreas transplants with portal enteric drainage. Arch Surg (2001) 0.75

Stability of bladder function two years following simultaneous pancreas-kidney transplantation. Transplant Proc (1995) 0.75

Results of a prospective, randomized double-blind study comparing standard vs low-dose OKT3 induction therapy. Transplant Proc (1993) 0.75

Invasive partial mole. Am J Clin Pathol (1986) 0.75

Are autoimmune diseases or glomerulonephritis affecting the development of panel-reactive antibodies in candidates for renal transplantation? Transplant Proc (2005) 0.75

Renal transplant blood flow on TcDPTA scan predicts recovery from delayed graft function. Transplant Proc (1990) 0.75

Portal-enteric pancreas transplantation at the University of Tennessee, Memphis. Clin Transpl (2000) 0.75

Glucose disappearance constant (KG) provides an alternative diagnostic marker of acute pancreas allograft rejection. Transplant Proc (1994) 0.75

Changes in abdominal wounds following treatment with sirolimus and steroids in a rat model. Transplant Proc (2006) 0.75